| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911184 | Lung Cancer | 2013 | 6 Pages |
Abstract
Maintenance therapy with vandetanib for patients with NSCLC after standard platinum doublet chemotherapy is well tolerated and may prolong PFS compared with placebo, and needs additional investigation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jin Seok Ahn, Ki Hyeong Lee, Jong-Mu Sun, Keunchil Park, Eun-Suk Kang, Eun Kyung Cho, Dae Ho Lee, Sang-We Kim, Gyeong-Won Lee, Jin-Hyoung Kang, Jong-Seok Lee, Jae-Won Lee, Myung-Ju Ahn,